Prenetics Global PRE
NASDAQ PRE
$26.29 +0.51 (+1.98%)
As of: Aug 27, 2026 · 3:59 PM EDT

Prenetics Global (PRE) Short term Debt (2022 - 2023)

Prenetics Global (PRE) posted quarterly Short term Debt of $4.2 million for Q4 2023, little changed year-over-year from $4.2 million in Q4 2022, and little changed quarter-over-quarter from $4.2 million in Q4 2022.

Prenetics Global (PRE) Short term Debt (2022 - 2023) Analysis & Trends

Prenetics Global (PRE) has reported Short term Debt for 2 consecutive years, with $4.2 million the latest figure, recorded in Q4 2023.

  • In Q4 2023, Short term Debt changed 0.15% year-over-year to $4.2 million; the TTM figure through Dec 2023 stood at $4.2 million (changed 0.15% YoY), while the FY2023 annual figure was $4.2 million, changed 0.15% from the prior year.
  • Short term Debt was little changed at $4.2 million in Q4 2023 per PRE's latest filing, from $4.2 million in the prior quarter.
  • Across five years, Short term Debt topped out at $12.1 million in Q1 2022 and bottomed at $4.2 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Prenetics Global 368.73 Mn 309.68 Mn 30.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 4.25 Mn
Dec 31, 2022 4.24 Mn
Jun 30, 2022 9.20 Mn
Mar 31, 2022 12.08 Mn